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The intracellular protozoan Leishmania can 
produce a spectrum of clinical diseases, ranging 
from a single cutaneous ulcer that spontane-
ously heals, to chronic cutaneous or mucocuta-
neous lesions that are nonhealing or slow to 
resolve, to visceral disease that is generally fatal 
in the absence of treatment. Mammalian host 
protection against Leishmania is dependent on 
the development of a Th1 response, which 
arms infected macrophages for enhanced leish-
manicidal capacity. Based largely on the exten-
sive data pertaining to L. major infection in 
BALB/c mice, the immunologic mechanisms 
underlying nonhealing forms of leishmaniasis 
in mice and humans have conventionally been 
investigated in the context of a parasite-driven, 
Th2-polarized response in which IL-4 is espe-
cially dominant (for review see reference 1). 
Th2 cell dominance, however, has failed to 
  adequately explain nonhealing or reactivated 
forms of cutaneous or visceral leishmaniasis in 
humans. Analysis of chronic, localized lesions 
in humans has revealed increased expression 
of proinfl  ammatory cytokines and high levels 
of IL-10 but low or undetectable amounts of 
Th2-associated cytokines (2, 3). Lesions in pa-
tients with reactivating post-kala-azar dermal 
leishmaniasis contained mainly CD3+ cells, with 
IL-10 and IFN-γ the predominant cytokines 
(4, 5). In human visceral leishmaniasis, elevated 
levels of IFN-γ mRNA have been found in 
target organs, such as the spleen and bone 
  marrow, accompanied by increased levels of 
IL-10 (6–8).
Accumulating evidence from other mouse 
models of nonhealing or disseminating forms 
of leishmaniasis have reinforced pathogenetic 
mechanisms that take into account the presence 
of parasite-driven Th1 responses that are sup-
pressed either in magnitude or function by IL-10. 
IL-10 is crucial for suppressing the healing 
  response in mice with cutaneous lesions caused 
by L. mexicana and in preventing clearance 
of L. donovani from liver and spleen (9–11). 
Even in the L. major–BALB/c infection model, 
Th2 cell immune polarization appears to be 
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IL-10 was produced by innate cells, as well as CD4+CD25+Foxp3+ and CD4+CD25−Foxp3− 
T cells in the chronic lesion. Nonetheless, only IL-10 production by antigen-specifi  c 
CD4+CD25−Foxp3− T cells, the majority of which also produced IFN-γ, was necessary 
for suppression of acquired immunity in Rag−/− reconstituted mice. Surprisingly, Rag−/− 
mice reconstituted with naive CD4+ T cells depleted of natural T regulatory cells developed 
more severe infections, associated with elevated levels of IL-10 and, especially, Th2 
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  superimposed on IL-10–mediated suppressive pathways to 
account for the hypersusceptibility of this mouse strain, as 
BALB/c IL-4Rα–defi  cient mice are not fully resistant until 
IL-10 function is also impaired (12). We have recently intro-
duced a model of nonhealing L. major in conventionally resis-
tant C57BL/6 mice, in which IL-10 functions in a Th1 
cell–polarized setting to prevent clinical cure, and have   argued 
that this model better refl  ects the conditions underlying non-
healing forms of clinical disease (13).
IL-10 has pleiotropic, primarily antiinfl  ammatory prop-
erties that include suppression of DC functions and rendering 
macrophages unresponsive to activation signals (for review 
see reference 14). IL-10 can be produced by many cell types, 
including B cells, macrophages, DCs, Th2 cells, and distinct 
populations of T reg cells. Importantly, the sources of IL-10 
in chronic forms of leishmanial disease in mice or humans 
  remains poorly defi  ned. Macrophages have been shown to 
  produce IL-10 in response to LPS plus FcR signaling by 
IgG-opsonized amastigotes in vitro (15); although there is 
no direct evidence that macrophages are a critical source of 
  infection-induced IL-10 in vivo, antigen–antibody complexes 
enhanced susceptibility via an IL-10–dependent pathway (11, 
16), as did transgenic overexpression of IL-10 by macro-
phages and other APCs (17). CD4+ T cells have also been 
implicated as an important source of IL-10 in BALB/c 
mice, insofar as treatment of IL-4Rα−/− BALB/c mice with 
a CD4-depleting antibody, or an anti–IL-10 receptor anti-
body, in each case promoted strong resistance against L. major 
(12). Furthermore, IL-10 production by CD25 Foxp3− 
CD4+ T cells was a strong correlate of disease progression in 
L. donovani–infected mice (18). Finally, naturally occurring 
CD4+CD25+Foxp3+ T reg cells have been identifi  ed in the 
healed lesions of C57BL/6 mice and have been shown to 
function in an IL-10–dependent manner to prevent sterile 
cure (19).
The possibility that an imbalance in the number or activ-
ities of natural T reg cells might explain nonhealing forms of 
leishmaniasis seems especially strong given the many exam-
ples of chronic viral, bacterial, and parasitic infections in 
  humans and mice where depletion of CD4+CD25+ T cells 
from PBMCs or lymphoid tissue was shown to increase 
  antigen-specifi  c proliferative or IFN-γ responses (for review 
see reference 20). Although naturally occurring T reg cells 
originate in the thymus and are controlled by the activity of 
the transcription factor Foxp3 (for review see reference 21), 
CD4+ T cells with regulatory activities can also be generated 
from conventional naive T cells after antigen encounter in 
the periphery (for review see references 22, 23). Antigen-
  induced, IL-10–producing CD4+ T cells—arising from 
CD4+CD25−Foxp3− cells and variably referred to as Tr1 
cells, adaptive T reg cells, or inducible T reg cells—have 
been found to regulate colitis induced by Heliobacter hepaticus 
infections and to suppress protective Th1 responses to Bordetella 
pertussis in mice (24, 25). In humans, IL-10–producing, induc-
ible T reg cells may limit immune responses to Mycobacterium 
tuberculosis antigens and to helminth antigens in patients with 
onchocerciasis (26, 27). IL-10–secreting CD8+ T cells that 
can suppress certain autoimmune responses represent   another 
distinct lineage of inducible T reg cells (28), though their role 
in infectious diseases has not yet been demonstrated. Thus, 
multiple T and non–T cell sources of IL-10 can potentially 
contribute to suppression of curative responses in chronic infec-
tions, and IL-10–  producing CD4+ T cells are themselves 
heterogeneous with respect to their origin, activation require-
ments, and mechanism of action.
The present studies were designed to clarify the relative 
contribution of innate and T cell–derived sources of IL-10 to 
nonhealing infection with L. major, emphasizing the respec-
tive roles of IL-10–producing CD4+ T cell subsets that func-
tion locally to control Th1 cell–mediated immunity and 
pathology in the skin.
RESULTS
T cell–derived IL-10 is produced by Foxp3+ and Foxp3− 
CD4+ cells
We previously reported on an isolate of L. major that  produces 
nonhealing lesions containing persistently high parasite bur-
dens after low dose, intradermal inoculation in C57BL/6 
mice (13). The immune response in the site of the chronic 
lesion is predominantly composed of IFN-γ–producing 
CD4+ T cells, with IL-4 and IL-13 detectable in only very 
low amounts. IL-10 was found to play an essential role in 
the evolution of the chronic lesion, as the parasites were 
  eff  ectively controlled in IL-10–defi  cient mice and in WT 
mice treated during the chronic phase with anti–IL-10 re-
ceptor antibody. The key features of the model are rein-
forced by new data presented in Fig. 1: after intradermal 
inoculation of 1,000 metacyclic promastigotes of L. major 
NIH/Sd, parasite numbers increased in the ear dermis dur-
ing the fi  rst 4–5 wk, followed by containment of parasite 
growth but an inability to reduce the parasite burden or 
  resolve the cutaneous lesion (not depicted) for up to 16 wk. 
The chronic lesion contained a 15-fold increase, relative to 
naive ears, in the number of CD4+ T cells that accumulated 
in the site. Ex vivo restimulation with PMA/ionomycin 
was  used to evaluate the cytokine-producing capacity of 
the CD4+ T cell subsets recovered from the ear dermis (Fig. 
1 B). No IFN-γ or IFN-γ/IL-10 double producers were 
observed from CD4+ T cells recovered from naive ears, al-
though a high proportion of the low numbers of the CD4+ 
T cells recovered from the steady-state dermis produced 
IL-10. In contrast, 25% of the CD4+ T cells in the chronic 
lesion (10 wk) produced IFN-γ, accompanied by ∼7.5% of 
CD4+ T cells that produced IL-10, of which approximately 
half produced both cytokines. A kinetic analysis during the 
early development of the eff  ector response revealed the pres-
ence of IFN-γ+/IL-10+ CD4+ T cells by 3 wk after infec-
tion (Fig. 1 C).
PMA/ionomycin stimulation of naive dermal CD4+ 
T cells indicated that all of the IL-10 production was con-
fi  ned to the resident CD25+ cells (Fig. 2 A). In contrast, in 
the cells recovered from the chronic lesion (10 wk), IL-10 JEM VOL. 204, February 19, 2007  287
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was produced by approximately equivalent numbers of 
CD25− and CD25+ cells, whereas the vast majority of the 
IFN-γ–producing cells were CD25−. Foxp3 staining, which 
provides a more stringent criterion for identifi  cation of natu-
ral T reg cells, indicated that at 3 wk after infection, ∼15% of 
the lesional CD4+ cells expressed Foxp3, and this frequency 
was more or less maintained throughout the chronic phase of 
disease (Fig. 2 B). Of note, a substantial number of the 
Foxp3+ cells were CD25−. IL-10 production by the CD25− 
cells was not confi  ned to the Foxp3+ population, however, 
because CD4+Foxp3+ and CD4+Foxp3− cells were each a 
source of IL-10 in the lesion. Kinetic analysis of IL-10 pro-
duction by CD4+Foxp3− and CD4+Foxp3+ cells showed 
that both populations were present during the early phase of 
the eff  ector response (3 wk after infection), suggesting that 
these cells are not a consequence of chronic antigen stimula-
tion in the infl  ammatory site but arise early and may be caus-
ally related to the evolution of the noncure phenotype.
The CD4+ T cell subsets in the chronic ear lesions were 
further characterized by ex vivo analysis of cytokine mRNA. 
The CD4+ cells were sort purifi  ed based on expression of 
CD25 and the integrin CD103, as the latter has been shown 
to be highly expressed in natural T reg cells accumulat-
ing in the dermal lesions of L. major–infected mice (29). 
As shown in Fig. 2 C, CD25+CD103+ cells were highly 
enriched for both Foxp3 and IL-10 expression but not 
IFN-γ. CD25−CD103+ cells also expressed Foxp3, inter-
mediate  levels of IL-10 message, and again no IFN-γ. Impor-
tantly, CD25−CD103− cells expressed high levels of IFN-γ 
and IL-10 but only low levels of Foxp3. Collectively, the 
data clearly show that infection with L. major NIH/Sd drives 
local IL-10 production by both CD4+CD25+CD103+Foxp3+ 
and CD4+CD25−CD103−Foxp3− T cells and suggest that 
as the later cells are the exclusive source of IFN-γ, they 
are also the source of the cells capable of production of 
both cytokines that can be recovered from the infl  am-
matory site.
The contribution of innate and T cell sources of IL-10 
to suppression
Because cell types in addition to CD4+ T cells may produce 
IL-10 and because macrophages, in particular, have been im-
plicated in IL-10 production in other nonhealing models of 
cutaneous leishmaniasis (11, 16, 30), experiments were de-
signed to evaluate the relative contribution made by CD4+ 
T cells versus innate cells to the IL-10–mediated suppression 
of immunity in L. major NIH/Sd–infected mice. Unfraction-
ated naive T cells from C57BL/10 or IL-10−/− mice were 
Figure 1.  CD4+ T lymphocytes producing both IFN-𝗄 and IL-10 
are associated with nonhealing lesions in C57BL/6 mice infected 
with L. major NIH/Sd. Mice were inoculated intradermally with 1,000 
metacyclic-stage parasites in each ear. (A) Parasite burdens in the ear 
lesions were monitored throughout the infection. Values represent the 
mean ± SD of six mouse ears at each time point during one experiment 
and are representative of at least three independent experiments. 
(B) 10 wk after infection, ear lesion cells or naive control ear cells were 
stimulated in vitro with PMA and ionomycin for 4 h and analyzed for intra-
cellular cytokine production. (C) Ear lesion cells were analyzed for cytokine 
production at the indicated time points after infection. All cells shown are 
TCRβ+CD4+ lymphocytes, and quadrant values are the percentage of 
total gated CD4+ T cells. The plots are from six pooled ears per time point 
from one experiment and are representative of at least three.288  IL-10–PRODUCING TH1 CELLS IN LEISHMANIASIS | Anderson et al.
adoptively transferred into RAG−/− or RAG−/− × IL-10−/− 
recipients, thereby restricting the source of IL-10 to either 
T cell or non–T cell compartments. 11 wk after transfer and 
infection, IL-10 was detected by ELISA in draining lymph 
node cells from RAG−/− and RAG−/− × IL-10−/− recipi-
ents of T cells from WT mice and was dependent on the 
  addition of exogenous parasite antigen (Fig. 3 A). IL-10 was 
not detected in the lymph nodes of recipients of IL-10−/− 
T cells. In contrast, IL-10 was detectable in the ear lesions 
from mice that received WT or IL-10−/− T cells and was 
produced in the absence of exogenous antigen, indicating 
that there is a non–T cell source of IL-10 in the infl  amma-
tory site. Ex vivo analysis by real-time PCR also indicated 
that IL-10 was being produced in the lesions of mice recon-
stituted with IL-10−/− T cells (Fig. 3 B). Furthermore, com-
parison of IL-10 production at the protein and message level 
suggests that the major source of IL-10 in the ear lesion was 
innate cells.
Figure 2.  CD4+ T cells producing IL-10 in response to infection with 
L. major NIH/Sd comprise multiple subsets. (A) Naive ear cells or cells 
from the chronic ear lesion were stimulated in vitro with PMA and ionomycin 
for 4 h and analyzed for intracellular cytokine production. (B) A kinetic analy-
sis of IL-10 production and Foxp3 expression was performed on in vitro–
restimulated lesional cells at the indicated time points. The data shown 
are TCRβ+CD4+ cells from six pooled ears from one experiment and are 
  representative of at least three independent experiments. Quadrant values 
are the percentage of total gated CD4+ T cells. (C) 10 wk after infection, 
TCRβ+CD4+ ear lesion cells were purifi  ed by cell sorting into three subsets 
according to cell surface expression of CD25 and CD103. Real-time PCR anal-
ysis was performed to quantify gene expression of Foxp3, IFN-γ, and IL-10. 
Data are expressed as the fold change relative to naive CD4+CD25− lymph 
node cells. Two independent experiments were performed with similar results.JEM VOL. 204, February 19, 2007  289
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To determine what eff  ect the source of IL-10 had on the 
Th1 eff  ector response, the number of Leishmania antigen-  specifi  c 
IFN-γ–producing cells was measured by fl  ow cytometry 
(Fig. 3 C). The mice that had received IL-10−/− T cells had 
signifi  cantly increased numbers of lesional IFN-γ–producing 
CD4+ T cells (9.2 ± 1.7 × 103 cells in RAG−/− mice and 
10.4 ± 2 × 103 cells in RAG−/− × IL-10−/− mice) com-
pared with the mice receiving IL-10–suffi   cient T cells (6.1 ± 
1.2 × 103 cells in RAG−/− mice and 6.6 ± 1.4 × 103 cells 
in RAG−/− × IL-10−/− mice), suggesting that the T cell–
  derived IL-10 had a greater infl  uence on the eff  ector response 
than the IL-10 derived from non–T cell sources. Most impor-
tantly, T cell–derived IL-10 exerted the greatest suppressive 
eff  ect on the ability of the recipient mice to control infection 
with L. major NIH/Sd (Fig. 3 D). At 11 wk, RAG−/− mice 
that received IL-10−/− T cells had signifi  cantly lower parasite 
burdens than RAG−/− × IL-10−/− recipients of WT T cells, 
demonstrating that the presence of IL-10 from T cells alone 
is suffi   cient to suppress killing. When IL-10 production was 
absent only from the innate compartment, parasite burdens 
were no diff  erent from the group containing both sources of 
IL-10, demonstrating that IL-10 from non–T cells, despite its 
relative abundance within the infl  ammatory site, contributes 
little to the suppression of immunity. The reconstituted ani-
mals with generalized IL-10 defi  ciency displayed the greatest 
resistance to infection, although their parasite burdens were 
not signifi  cantly diff  erent (P > 0.05) than the mice defi  cient 
in T cell–derived IL-10 only. Of note, the T cell– reconstituted 
mice in each case controlled the infection far better than the 
unreconstituted mice, demonstrating that the acquired resistance 
Figure 3.  T cells are the dominant source of IL-10–mediated 
immune suppression in L. major NIH/Sd infection. 2 × 106 T lympho-
cytes from lymph nodes of naive C57BL/10 or IL-10−/− mice were 
  adoptively transferred into RAG−/− or RAG−/− × IL-10−/− recipients, 
followed by intradermal inoculation of L. major NIH/Sd 1 d later. 11 wk 
after infection, mice were killed for analysis. (A) Draining lymph node cells 
or ear lesion cells were stimulated in vitro with BMDCs in the absence or 
presence of L. major antigen for 72 h, followed by IL-10 measurement by 
ELISA. Groups are labeled with the source of donor T cells specifi  ed below 
either RAG−/− or RAG−/− × IL-10−/− recipient mice. Data are the mean ± 
SD of triplicate samples from one experiment. The experiment was per-
formed three times with similar results. (B) Real-time PCR was performed 
on ear lesion tissue for quantifi  cation of IL-10. The values are the fold 
change in gene expression relative to naive controls. Data are the mean ± 
SD of four ears from one experiment and are representative of three 
  experiments. (C) Ear lesion cells were stimulated in vitro with BMDCs or 
BMDCs infected with L. major amastigotes. After overnight incubation, 
monensin was added in the fi  nal 4 h, followed by measurement of intra-
cellular IFN-γ. The plots shown are from one experiment, and the values 
in the upper left quadrants are the total number of IFN-γ+CD4+ cells/
ear × 10−3 and are the mean ± SD of three independent experiments. 
(D) Parasite burdens in the ear lesions were enumerated by limiting 
 dilution.  Unreconstituted  RAG−/− and RAG−/− × IL-10−/− mice are also 
shown as controls. The data points are from six mice from one experiment 
and are representative of three independent experiments. Horizontal lines 
represent geometric means.290  IL-10–PRODUCING TH1 CELLS IN LEISHMANIASIS | Anderson et al.
is only partially compromised by IL-10. Because these exper-
iments involved transfers of T cells alone, the potential con-
tribution from antibody-mediated IL-10 induction through 
FcR signaling on macrophages would be absent. The trans-
fers into RAG−/− and RAG−/− × IL-10−/− recipient mice 
were therefore performed using total splenocytes from WT 
or IL-10−/− mice. The results again showed that T cells 
were the dominant source of IL-10–mediated suppression of 
  immunity in the reconstituted mice (Fig. S1, available at 
http://www.jem.org/cgi/content/full/jem.20061886/DC1), 
with no signifi  cant diff  erence observed between the RAG−/− 
and RAG−/− × IL-10−/− recipient groups. Collectively, the 
data indicate that IL-10 is locally produced by both T cells 
and innate cells but that antigen-specifi  c, T cell–derived IL-10 
is both necessary and suffi   cient for suppression of acquired 
resistance to infection with L. major NIH/Sd.
Figure 4.  IL-10 produced by antigen-induced CD4+CD25−Foxp3− 
T cells is necessary for the suppression of immunity. CD4+ lymph 
node T cells from naive WT or IL-10−/− mice were separated into CD25− 
and CD25+ fractions and adoptively cotransferred in a 10:1 ratio in 
the indicated combinations into RAG−/− recipients, followed by intra-
dermal inoculation of 1,000 L. major NIH/Sd metacyclic promastigotes 
1 d later. (A) 10 wk after infection, mice were killed, and lesion cells 
were stimulated with PMA and ionomycin for 4 h for measurement of 
intracellular IL-10 and IFN-γ. CD4+ cells were gated on CD25−CD103− 
and CD25+CD103+ for identifi  cation of subsets of IL-10–producing 
cells. Foxp3 expression and IFN-γ/IL-10 was measured from total CD4+ 
cells. (B) Draining lymph node cells were stimulated in vitro with BMDCs 
in the absence or presence of L. major antigen for 72 h, followed 
by measurement of IL-10 by ELISA. Values shown are the mean ± 
SEM. (C) Parasite burdens in ear lesions were measured at 5 and 
10 wk. The data points are from six mice in each group. The experi-
ments were performed twice with similar results. Horizontal lines 
  represent geometric means. *, P = 0.0005; **, P < 0.0001 in compari-
son to mice receiving CD25+/− T cells from IL-10–sufficient mice. 
Ag, antigen.JEM VOL. 204, February 19, 2007  291
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CD4+CD25−Foxp3− cells provide the major contribution 
to IL-10–mediated suppression by T cells
To evaluate the relative contribution of the CD4+IL-10+ 
subsets to the suppression of protective immunity in L. major 
NIH/Sd–infected mice, CD4+ cells from naive WT or 
IL-10−/− mice were sort purifi  ed into CD25− and CD25+ 
subsets and cotransferred into RAG−/− mice in the following 
combinations: CD25−WTCD25+WT, CD25−10KOCD25+WT, 
and CD25−WTCD25+10KO, followed by infection 1 d later. 
The infections were allowed to proceed to the chronic phase 
for the analysis of IL-10 production and its correlation with 
parasite burdens in the ear. When IL-10–suffi   cient cells of 
each subset were cotransferred, the cell numbers and cyto-
kine profi  les in the lesion refl  ected those observed in intact 
mice (Fig. 2 A): CD4+ T cells able to produce IL-10 
were found within both the CD25+CD103+/Foxp3+ and 
CD25−CD103−/Foxp3− populations, with a high proportion 
of the CD4+IL-10+ cells also positive for IFN-γ (Fig. 4 A). 
In contrast, in mice that received IL-10−/− CD4+CD25− 
cells, the IL-10–producing cells were confi   ned to the 
CD25+CD103+/Foxp3+ populations, and importantly, no 
IFN-γ/IL-10 double producers were observed. Mice that 
  received IL-10−/− CD4+CD25+ cells showed residual IL-10 
production from CD25+CD103+/Foxp3+ cells, suggesting 
that the cotransferred WT CD25− cells contained contami-
nating natural T reg cells, or there was conversion of low 
numbers of Foxp3− to Foxp3+ cells during infection (31). 
More importantly, these mice maintained normal IL-10 pro-
duction from CD4+CD25−CD103− and CD4+Foxp3− cells, 
suggesting that antigen-specifi  c IL-10 production by CD4+ 
T cells during infection does not appear to be infl  uenced by 
IL-10 production by natural T reg cells. These recipients also 
revealed that when IL-10 production was primarily confi  ned 
to the CD25−/Foxp3− population, a clear majority (78%) of 
the CD4+ T cells recovered from the lesion also produced 
IFN-γ. ELISA measurement of IL-10 (Fig. 4 B) and IFN-γ 
(not depicted) in the draining lymph nodes reinforced the 
ear lesion data, demonstrating that antigen-specifi  c cytokine 
  secretion was dependent on the transfer of IL-10–suffi   cient 
CD25− cells. Finally, the ability of IL-10 to suppress the 
  development of protective immunity in the reconstituted 
mice was dependent on its production by CD25− Foxp3− 
cells, as mice receiving IL-10−/− CD25− cells were able to 
control the infection and displayed a 100-fold reduction in 
mean parasite burden at 10 wk, regardless of whether the 
  cotransferred natural T reg cells were IL-10 competent or not 
(Fig. 4 C). Thus, IL-10 from CD4+CD25−Foxp3− T cells, 
the majority of which also produce IFN-γ, plays the domi-
nant role in the pathogenesis of the chronic, noncuring infec-
tion in these mice.
A caveat of the adoptive cotransfers is that CD25, though 
a reliable marker of natural T reg cells in populations of naive 
cells, may not be suitable to track the fate of the original 
CD25+ and CD25− subsets after their homeostatic prolifera-
tion and L. major–driven activation during 10 wk in vivo. To 
address this concern, congenic mice were used as a source of 
the naive CD25+ and CD25− cells at the time of cotransfer. 
When lesional CD4 cells were analyzed 10 wk later for 
CD45.1 expression in relation to CD25, ∼90% of the cells 
were found to have maintained their original phenotype in 
each case (Fig. S2, available at http://www.jem.org/cgi/
content/full/jem.20061886/DC1), thereby justifying the use 
of CD25 as a marker of natural T reg cells in the analysis of 
the cotransfer experiments depicted in Fig. 4. Furthermore, 
the RAG−/− reconstituted mice maintained relative frequen-
cies of CD25− and CD25+ cells in the lesions that approxi-
mated those observed in intact mice (Fig. 2).
Removal of natural T reg cells exacerbates infection
Although IL-10 derived from natural T reg cells does not ap-
pear to contribute greatly to the suppression of immunity in 
C57BL/6 mice infected with L. major NIH/Sd, these cells 
might still play a critical role in suppression by production of 
other regulatory cytokines (e.g., TGF-β) or by cell contact–
dependent mechanisms. To determine what eff  ect, if any, the 
presence of natural T reg cells had on the development of 
the immune response in this infection, CD4+ T cells from 
the lymph nodes of naive C57BL/10 mice were depleted or not 
of CD25+ cells by sort purifi  cation and adoptively transferred 
into RAG−/− recipients. 10 wk after transfer and infection, 
the cell composition and the parasite burdens in the lesions 
were measured. Although Foxp3+ cells still accumulated in 
the ear lesions of mice reconstituted with CD25+-depleted 
cells (3.6% of CD4+ T cells), their frequency was signifi  -
cantly lower than in the lesions of mice receiving the total 
CD4+ cells (11.7% of CD4+ T cells; Fig. 5 A). Nonetheless, 
the mice receiving the CD25+-depleted cells had higher par-
asite burdens, suggesting that, if anything, the natural T reg 
cells appeared to play a role in promoting host resistance (Fig. 
5 A). Because a percentage of the sort purifi  ed CD4+CD25− 
cells are Foxp3+ (Fig. 2 C) and because homeostatic prolifer-
ation of the transferred CD4+CD25− cells may result in an 
outgrowth of the Foxp3+ lineage (32), we used bicistronic 
mice with an enhanced GFP reporter inserted into the Foxp3 
locus as a source of CD4+ T cells from which natural T reg 
cells might be more faithfully removed (33). 6 wk after 
adoptive transfer and infection, mice that had received 
CD4+GFP− cells had few Foxp3+ cells in the draining lymph 
nodes (2.3%) and at the site of infection (1.5%) compared 
with the group that received unselected CD4+ cells (8 and 
23.8%, respectively; Fig. 5 B). In agreement with the experi-
ment involving transfer of CD25+-depleted cells, the absence 
of Foxp3−GFP+ cells resulted in a signifi  cant increase in par-
asite burdens in the ear. The termination of the experiment 
at 6 wk after infection as opposed to a more chronic stage of 
infection was conditioned by the mice becoming moribund, 
demonstrating weight loss and signs of colitis that were con-
fi  rmed on necropsy (unpublished data). The development of 
colitis in T cell–reconstituted RAG −/− mice is taken as 
additional evidence for the functional depletion of natural 
T reg cells in the these recipients (34, 35). The frequency of 
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IFN-γ, was slightly greater than in the mice transferred with 
total CD4+ cells (unpublished data). These results were con-
fi  rmed by the real-time PCR analysis of lesional cytokine 
mRNA, which revealed slight increases in IL-10, IFN-γ, and 
TNF mRNA levels in mice reconstituted with the Foxp3-
depleted cells (Fig. 6). Interestingly, the lesional cells in these 
mice also showed an increase in IL-4, IL-5, and IL-13 mRNA 
expression, indicating that natural T reg cells functioned to 
suppress the development of a Th2 response. Thus, naive 
CD4+Foxp3− T cells alone were capable of being activated 
by the L. major NIH/Sd strain to produce IFN-γ and/or 
IL-10 and of being recruited to the site of infection in the 
skin, where they established the conditions necessary for the 
development of contained, but chronic, nonhealing lesions. 
The infl  uence of natural T reg cells in this process appeared 
to be a global suppression of the eff  ector response, including 
IL-10–producing Th1 cells and, especially, Th2 cells, so that 
on balance their activities may actually have promoted host 
immunity in the infl  ammatory site.
D  I  S  C  U  S  S  I  O  N 
It is well established that endogenous IL-10 is a central medi-
ator of immune homeostasis, necessary to keep in check the 
strong infl   ammatory reactions that can accompany the 
  expression of antimicrobial immunity in local tissues. A con-
sequence of the balance struck between host immunity and 
pathology can be chronic or persistent infection, and the 
  absence of IL-10 has been shown to result in more effi   cient 
clearance of a variety of pathogens (for review see reference 
23). In leishmaniasis, aside from the Th2 cell–polarizing con-
ditions that underlie the extreme susceptibility of BALB/c 
mice to cutaneous strains of Leishmania, chronic forms of 
  cutaneous or visceral disease in humans and in other mouse 
models are better explained by the presence of ongoing Th1 
responses that are compromised in intensity or function by 
IL-10 (for review see reference 36). As many innate cells and 
lymphocyte subsets can produce IL-10, the relative contribu-
tion of these cells to the antiinfl  ammatory/immunosuppressive 
cascade in sites of chronic infection has not been carefully 
defi  ned. The present study addresses the dominant source of 
IL-10–dependent immune suppression induced by a strain of 
L. major that produces nonhealing dermal lesions in the face 
of a strong Th1 response in C57BL/6 mice. The infection 
induced localized recruitment and production of IL-10 from 
innate cells, as well as from CD4+CD25+Foxp3+ natural 
T reg cells and CD4+CD25−Foxp3− T cells. The latter cells 
Figure 5.  The absence of natural T reg cells exacerbates the infection. 
(A) 2 × 106 naive CD4+CD25− T cells alone or in combination with 
2 × 105 CD4+CD25+ cells were adoptively transferred into RAG−/− recipi-
ents, followed by intradermal inoculation with L. major NIH/Sd 1 d later. 
10 wk after infection, mice were killed for parasite burden and immune 
analysis. Surface CD25 and nuclear Foxp3 expression were measured in 
lesional cells, and the quadrant values represent the percentage of total 
CD4+ cells in the ear. For parasite burdens, data points are from 10 ears 
(from fi  ve mice) from one experiment and are representative of at least 
three independent experiments. Horizontal lines represent geometric 
means. *, P = 0.008. (B) 2 × 106 CD4+GFP− cells from naive Foxp3-GFP 
knock-in mice were adoptively transferred alone or in combination with 
2 × 105 CD4+GFP+ cells into RAG−/− recipients. 6 wk after infection, mice 
were killed, and lesions were analyzed for parasite burdens and cell com-
position. Foxp3 expression was measured in draining lymph nodes and ear 
lesions. Parasite burden data points are from six mice. The experiment was 
performed three times with similar results. Horizontal lines represent 
geometric means. **, P = 0.014.JEM VOL. 204, February 19, 2007  293
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appear to be closely linked to the Th1 eff  ector response, in 
that the majority also produced high amounts of IFN-γ. In 
Rag−/− reconstituted, infected mice, the IL-10–producing 
Th1 cells were generated in the absence of either natural 
T reg cells or IL-10 from innate sources and, most impor-
tantly, were found to play a necessary role in the suppression 
of protective immunity in the site. The data are consistent 
with a regulatory pathway that relies not on a committed lin-
eage of cells or on suboptimal conditions of immune activa-
tion, but on a strong proinfl  ammatory   environment that 
drives Th1 cells through a program of development that in-
cludes IL-10 secretion as a mechanism of feedback control.
The studies have documented IL-10 production   associated 
with both CD4+CD25+Foxp3+ and CD4+CD25−Foxp3− 
T cells that accumulate in the chronic lesion, and by using 
RAG−/− mice reconstituted with naive CD4+ T cells 
that were IL-10–defi  cient in either the CD25+Foxp3+ or 
CD25−Foxp3− subset, they have clarifi  ed the possible inter-
dependence of these cells and their respective contributions 
to the suppression of protective immunity. IL-10 produced 
by CD25−Foxp3− cells was necessary for the evolution of 
the nonhealing phenotype, because mice receiving naive 
CD25−Foxp3− cells from IL-10–defi  cient mice developed 
strong resistance, even when cotransferred with CD25+Foxp3+ 
cells from IL-10–suffi   cient mice. Although we have found it 
diffi   cult to stain for intracellular IL-10 in antigen-stimulated 
cells recovered from the ear dermis, the antigen specifi  city of 
the IL-10 response was substantiated using draining lymph node 
cells and was only detected in mice receiving CD25−Foxp3− 
cells from IL-10–suffi   cient mice.
Because natural T reg cells might suppress immunity by 
IL-10–independent mechanisms, their contribution was fur-
ther evaluated in RAG−/− mice reconstituted with naive 
CD4+ T cells depleted or not of CD25+ cells. The infl  uence 
of natural T reg cells was, surprisingly, to promote host resis-
tance. Thus, transfer of FACS-purifi  ed naive CD4+CD25− 
T cells to RAG−/− mice (Fig. 5 A) resulted in signifi  cantly 
greater parasite burdens 10 wk after infection compared with 
mice receiving total CD4+ T cells, despite the accumulation 
of fewer numbers of CD25+Foxp3+ cells in the chronic 
  lesion. Transfer of CD4+ T cells from bicistronic reporter 
mice that were more effi   ciently depleted of Foxp3+ cells pro-
duced similar results and also induced colitis, confi  rming the 
functional depletion of the natural T reg cells. The present 
work suggests that in the absence of Foxp3+ cells, a mecha-
nism of suppression was removed that promoted expansion 
of antigen-induced CD4+ T cells regardless of eff  ector type, 
including IL-10–producing Th1 and Th2 cells, so that on 
balance there were more disease-exacerbating T cells in the 
infl  ammatory site. The eff  ects on Th2 cytokines were espe-
cially interesting as early, albeit transient, Th2 responses have 
been observed in L. major–infected, resistant mice (37, 38). 
The data suggest a role for natural T reg cells in extinguishing 
this early response in intact mice. Similar eff  ects of CD25+ 
T reg cell depletions at the time of challenge in intact mice 
have been reported in other nonhealing models of cutaneous 
leishmanaisis, including L. amazonensis–infected C57BL/6 
mice (39) and L. major–infected BALB/c mice (40, 41), 
which in each case resulted in increased IL-4 production and 
more rapid development of early lesions. Although unregu-
lated Th2 cell development might have contributed to the 
enhancement of L. major NIH/Sd infection in Rag−/− mice 
reconstituted with CD4+ T cells depleted of CD25+ or 
Foxp3+ cells, it should be emphasized that, in intact mice, 
the IL-10–dependent, nonhealing phenotype develops in the 
absence of a sustained Th2 response and proceeds normally in 
C57BL/6 IL-4−/− mice (13). The reconstitution experiments 
using defi  ned and carefully monitored CD4+ T cell subsets 
demonstrate that the L. major NIH/Sd strain drives IL-10 
production by CD4+ CD25−Foxp3− T cells independent of 
natural T reg cells, and that this response is necessary and suf-
fi  cient for the evolution of noncure infections.
Although natural T reg cells appear to modulate the 
  development of the eff  ector response at the outset of infec-
tion and play an important role in preventing the complete 
elimination of L. major in the skin after clinical cure (19), 
in chronic infl  ammatory lesions natural T reg cells contend 
with IL-10–producing Th1 cells as a subordinate component 
of the homeostatic suppressor response. The relative roles 
that these CD4+ T cell subsets play in infection outcomes 
  involving healing versus nonhealing strains of L. major is 
  consistent with the functions postulated for natural and antigen-
inducible T reg cell subsets within diff  erent immunologic 
Figure 6.  Natural T reg cells suppress Th2 cell development. 
2 × 106 CD4+GFP− cells from naive Foxp3-GFP knock-in mice were 
adopti  vely transferred alone (shaded bars) or in combination with 2 × 105 
CD4+GFP+ cells (open bars), followed by infection 1 d later. 6 wk after 
infection, mice were killed, and real-time PCR was performed on RNA 
isolated from ear lesions. Values shown are the mean ± SEM and are 
relative gene expression normalized to 18S rRNA. Data were generated 
from cells pooled from six mice in each group and are representative of 
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settings   involving high- versus low-level infl  ammation, re-
spectively (23, 42).
What is the relationship of the IL-10–producing Th1 
cells that arise in response to L. major NIH/Sd infection to 
other antigen-inducible T reg cell populations that have been 
described in mouse and human infections involving, for ex-
ample, B. pertusis, H. hepaticus, Onchocerca volvulus, Plasmodium 
falciparum, and M. tuberculosis (24–27, 43)? In particular, what 
is their relationship to Tr1 cells that are often cited as the rel-
evant model of extrathymically induced, IL-10–producing 
CD4+ T cells? Tr1 cells are generated under tolerizing con-
ditions, requiring high concentrations of IL-10, immunosup-
pressive drugs, and/or immature DCs for their diff  erentiation 
(44–47). In contrast, the L. major–induced, IL-10–producing 
CD4+ T cells appear to be generated under conditions that 
drive strong Th1 responses, and their generation after transfer 
of naive CD4+ T cells into Rag−/− × IL-10−/− mice pro-
vides direct evidence that they are not dependent on innate 
sources of IL-10 for their diff  erentiation or suppressive 
  function. More importantly, the cytokine profi  les of the cells 
are clearly distinct, as the majority of the L. major–induced, 
IL-10–producing CD4+ T cells also produced IFN-γ, 
whereas Tr1 cells, particularly in the mouse, produce high 
levels of IL-10 with or without TGF-β, but little or no IFN-γ 
(for review see reference 48). Although IL-10 single pro-
ducers were found to accumulate in the chronic lesions of 
intact mice, the reconstitution experiments revealed that when 
natural T reg cells were eliminated as a source of IL-10, the 
vast majority of the IL-10–producing CD4+CD25−Foxp3− 
T cells also produced IFN-γ.
The production of IL-10 from T cells participating in a 
Th1 response has been a common fi  nding in patients with 
chronic infections (for review see reference 49). They have 
been observed, for example, in CD4+ T cell clones from 
bronchoalveolar lavage of active pulmonary tuberculosis 
  patients, T cell lines from patients with Lyme disease and 
  peripheral blood CD4+ T cells from patients with acute 
P. falciparum malaria (50–52). In mice, a high frequency of 
Th1 cells generated in response to immunization with killed 
Brucella abortus– or T. gondii–irradiated tachyzoites, or infec-
tion with infl   uenza virus, were found to coexpress IL-10 
(53–55). It is possible that the antigen-specifi  c,  IL-10–
  producing CD4+ T cells described in other chronic infections 
(for review see reference 22) might, on closer examination, 
be found to simultaneously produce IFN-γ. The fact that 
IL-12 instructs both IFN-γ and IL-10 secretion by anti-
CD3– or PHA–activated human T cells (56, 57) suggests that 
Th1 responses undergo a normal autoregulatory program of 
development. In recent experiments, IL-12 induction of 
IFN-γ was shown to provide an obligate signal for local 
  reactivation of IL-10 production by eff   ector Th1 cells in 
T. gondii–infected mice, providing further evidence that con-
ditions promoting Th1 cell immunity also establish a negative 
feedback loop to minimize tissue injury in the infl  amma-
tory  site (58). Recent experiments indicate that an IL-10 
  secretion by IFN-γ+T-bet+Foxp3− cells recovered from 
T. gondii–  infected mice is less stable and requires more sus-
tained acti  vation compared with their production of IFN-γ, 
and have clearly established the duality of purpose of these 
cells for maintaining strong antimicrobial immunity and lim-
iting collateral damage in the host (see Jankovic et al. [59] on 
p. 273 of this issue).
Our studies are the fi  rst, so far as we are aware, to for-
mally demonstrate a role for IL-10–producing Th1 cells in 
the pathogenesis of chronic infection and suggest a similar 
role for these cells in the chronic human infections for which 
T cells producing both IFN-γ and IL-10 have been  described. 
In addition, the observations may be relevant to other non-
curing forms of leishmaniasis, in particular visceral disease, 
for which IL-10 production by CD25−Foxp3−CD4+ T cells 
in spleens from L. donovani–infected mice (60), and in splenic 
aspirates from patients with active disease (Nylen, S.,  personal 
communication), has recently been described. The results 
begin to inform the paradoxical observations previously 
  reported that the nonhealing L. major strain induces an ear-
lier and stronger Th1 response than a healing strain (13). 
It remains to be determined how the L. major NIH/Sd 
strain survives the initial onslaught of activating cytokines. 
The   appearance of the IFN-γ+IL-10+ Foxp3−CD4+ T cells 
in the inoculation site as early as 3 wk after infection might 
suggests that the sequential commitment of Th1 cells to 
  local IL-10 secretion (61) is suffi   ciently contracted, so as to 
prevent eff  ective parasite elimination before the onset of 
  homeostatic control.
MATERIALS AND METHODS
Mice and reagents. The following mice were used in this study and were 
purchased from Taconic Farms: C57BL/6J, C57BL/10SgSnAi, B6.SJL 
Cd45a(Ly5a)/NAi, C57BL/10SgSnAi-[ko]IL10N10, C57BL/10SgSnAi-
[ko]RAG2, and C57BL/10SgSnAi-[ko]IL10-[ko]RAG2N12. Foxp3-GFP 
knock-in mice were generated by Bettelli et al. (33) and were kindly sup-
plied to us by Y. Belkaid (National Institutes of Health, Bethesda, MD). All 
mice were maintained in the NIAID animal care facility under specifi  c 
pathogen-free conditions and were used under a study protocol approved by 
the NIAID Animal Care and Use Committee.
Parasite preparation and intradermal inoculation. L. major strain 
NIH/Sd (MHOM/SN/74/SD) was cultured in medium 199 with 20% 
heat-inactivated FCS (Gemini Bio-Products), 100 U/ml penicillin, 100 μg/
ml streptomycin, 2 mM l-glutamine, 40 mM Hepes, 0.1 mM adenine (in 
50 mM Hepes), 5 mg/ml hemin (in 50% triethanolamine), and 1 mg/ml 
6-biotin (M199/S). Infective-stage metacyclic promastigotes of L. major 
were isolated from stationary cultures by density gradient centrifugation, as 
previously described (62). 1,000 metacyclic promastigotes were inoculated 
into the ear dermis using a 30-gauge needle in a volume of ∼5–10 μl. The 
development of the lesion was monitored by measuring the diameter of the 
ear lesion with a direct-reading vernier caliper (Thomas Scientifi  c).
Processing of ear tissue and estimation of parasite load. Parasite titra-
tions were performed as previously described (37). The two sheets of in-
fected ear dermis were separated, deposited in DMEM containing 100 U/ml 
penicillin, 100 μg/ml streptomycin, and 0.2 mg/ml Liberase CI purifi  ed 
enzyme blend (Roche Diagnostics Corp.), and incubated for 2 h at 37°C. 
Digested tissue was placed in a grinder and processed in a tissue homogenizer 
(Medimachine; Becton Dickenson). Tissue homogenates were fi  ltered 
through a 70-μm cell strainer (Falcon Products) and serially diluted in 96-well JEM VOL. 204, February 19, 2007  295
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fl  at-bottom microtiter plates containing biphasic medium prepared using 
50 μl of NNN medium containing 30% defi  brinated rabbit blood overlaid 
with 50 μl M199/S. The number of viable parasites in each sample was 
  determined from the highest dilution at which promastigotes could be 
  detected after 7–14 d of incubation at 25°C.
Restimulation of leukocytes for cytokine analysis. To characterize 
leukocytes in the inoculation site, the ears were collected, and the ventral 
and dorsal dermal sheets were prepared as described in the previous section. 
After preparation, cells were analyzed for surface phenotype by fl  ow cytometry. 
For in vitro restimulation, unfractionated cervical draining lymph node cells 
were incubated for 72 h at 37°C, 5% CO2 at a concentration of 2 × 
106 cells in 200 μl RPMI 1640 containing 10% FCS, 10 mM Hepes, 
l-glutamine, and penicillin/streptomycin in round-bottom 96-well plates in 
the presence of 2 × 105 bone marrow–derived DCs (BMDCs) with or with-
out 50 μg/ml of freeze-thaw Leishmania antigen prepared from NIH/Sd 
  stationary phase promastigotes. For restimulation of dermal lymphocytes, 
cells were stimulated with BMDCs or amastigote-infected BMDCs over-
night, with monensin (Golgistop; BD Biosciences) added during the last 4 h. 
For measurement of intracellular IL-10, dermal leukocytes were incubated 
with 10 ng/ml PMA and 500 ng/ml ionomycin for 4 h in the presence of 
monensin (Golgistop). The cells were analyzed for surface markers and intra-
cytoplasmic staining for cytokines.
Immunolabeling and fl  ow cytometry. The following antibodies used 
for immunophenotyping were purchased from BD Biosciences: APC anti–
mouse TCRβ chain (H57-597), PE-Cy5 anti–mouse CD4(L3T4) (RM4-5), 
PE or APC anti–mouse CD25(PC61), FITC anti–mouse CD103(M290), 
FITC anti–mouse IFN-γ (XMG-1.2), and PE anti–mouse IL-10 (JES5-
16E3). Foxp3 staining was performed using eBioscience reagents according 
to manufacturer’s protocol. The isotype controls used (all obtained from BD 
Biosciences) were rat IgG2b (A95-1), rat IgG2a (R35-95), and hamster IgG, 
group 2 (Ha4/8). Before staining, lymph node or dermal cells were incu-
bated with an anti-Fc III/II receptor mAb (2-4G.1) in PBS containing 0.1% 
BSA and 0.01% NaN3. The staining of surface and intracytoplasmic mark-
ers was performed sequentially: the cells were stained fi  rst for their surface 
markers, followed by a permeabilization step and staining for IFN-γ and IL-10. 
For each sample, 250,000 cells were acquired for analysis. The data were 
collected and analyzed using CellQuest Pro software (BD Biosciences) and 
a fl  ow cytometer (FACSCalibur; BD Biosciences). The lymphocytes from 
ear cells were identifi  ed by characteristic size (forward light scatter) and granu-
larity (side light scatter) and by lymphocyte surface phenotype.
Cell purifi  cation for adoptive transfers. Whole CD4+ T cells were 
  purifi  ed from spleens and lymph nodes of mice by negative selection (Miltenyi 
Biotec). CD4+CD25+ and CD4+CD25− subsets were sort purifi  ed using 
a sorter (FACSVantage; BD Biosciences), after which >99.9% were pure. 
Foxp3 expression was measured on sorted cells by fl  ow cytometry and real-
time PCR to confi  rm natural T reg cell and naive cell populations, respec-
tively. For adoptive transfer, recipients received 2 × 106 whole CD4+ cells 
intravenously or, where indicated in the fi  gures, 2 × 106 CD4+CD25− cells 
with or without 2 × 105 CD4+CD25+ cells. In some cases, splenocytes were 
depleted of erythrocytes with ACK lysis buff  er (Cambrex) and used for 
adoptive transfer into RAG−/− recipients. For Foxp3-GFP knock-in mice, 
purifi  ed CD4+ T cells were sorted into GFP− and GFP+ fractions and trans-
ferred intravenously into recipient mice in the same relative numbers.
Real-time PCR. For analysis of gene expression, ears were removed and 
immediately placed in RNAlater (QIAGEN). Ear tissue was mechanically 
disrupted using liquid nitrogen and a mortar and pestle. Homogenates were 
passed through Qiashredder columns, and RNA was purifi   ed using an 
RNAeasy mini kit (QIAGEN), according to the manufacturer’s protocol. 
Reverse transcription was performed using the Superscript III First-Strand 
Synthesis System for RT-PCR (Invitrogen). Real-time PCR was performed 
on a sequence detection system (ABI Prism 7900; Applied Biosystems). 
PCR primer probe sets were predeveloped gene expression assays designed 
by Applied Biosystems, and the quantities of products were determined by 
the comparative threshold cycle method using the equation 2−∆∆Ct to deter-
mine the fold increase in product. Each gene of interest was normalized to 
the 18S rRNA endogenous control, and the fold change in expression is dis-
played as relative to naive controls.
Statistical analysis. Statistical signifi  cance between groups was deter-
mined by the unpaired, two-tailed student’s t test using Prism software 
(GraphPad).
Online supplemental material. Fig. S1 shows parasite burdens in recipient 
mice of whole splenocytes. Fig. S2 uses the congenic marker CD45.1 to fol-
low the fate of transferred CD25+ cells. Online supplemental material is 
available at http://www.jem.org/cgi/content/full/jem.20061886/DC1.
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